Table 2 Postoperative tumour characteristics for patients with available histopathological information according to treatment
NACa | NoNACb | All | |
|---|---|---|---|
Patients, n (%) | 67 (13%) | 447 (87%) | 514 (100%) |
Pathological T category, n (%) | |||
Downstaging of primary tumour | |||
pT0 | 16 (24%) | 38 (9%) | 54 (11%) |
pTa | 2 (3%) | 13(3%) | 15 (3%) |
pTis | 6 (9%) | 21(5%) | 27 (5%) |
pT1 | 5 (7%) | 24(5%) | 29 (6%) |
Residual muscle-invasive disease | |||
pT2 | 12 (18%) | 92 (21%) | 104 (20%) |
pT3 | 18 (27%) | 212 (47%) | 230 (45%) |
pT4 | 8 (12%) | 47 (11%) | 55 (11%) |
Pathological N category, n (%) | 65 (15%) | 368 (85%) | 433 (100%) |
pN+ | 16 (25%) | 129 (35%) | 145 (33%) |
pN0 | 49 (75%) | 239 (65%) | 288 (67%) |